NCT00225524View on ClinicalTrials.gov

Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 30, 2004

Conditions
Depression
Interventions
DRUG

Effexor XR

Trial Locations (73)

462-0831

Nagoya

467-8602

Nagoya

272-0034

Ichikawa

272-0827

Ichikawa

810-0001

Fukuoka

810-0801

Fukuoka

812-8582

Fukuoka

813-0044

Fukuoka

816-0801

Kasuga

802-0006

Kitakyushu

802-8555

Kitakyushu

804-0062

Kitakyushu

830-0011

Kurume

816-0943

Ohnojyo

730-8518

Hiroshima

731-0121

Hiroshima

734-8551

Hiroshima

737-0023

Kure

047-0032

Otaru

006-8555

Sapporo

060-0042

Sapporo

060-8648

Sapporo

063-0061

Sapporo

064-0946

Sapporo

065-0012

Sapporo

662-0832

Nishinomiya

300-8585

Tsuchiura

305-8576

Tsukuba

920-8641

Kanazawa

025-0033

Hanamaki

215-0021

Kawasaki

216-8511

Kawasaki

228-0803

Sagamihara

229-1103

Sagamihara

220-0004

Yokohama

224-8503

Yokohama

225-0012

Yokohama

236-0004

Yokohama

241-0081

Yokohama

245-8575

Yokohama

238-8558

Yokosuka

861-1116

Kikuchi

852-8501

Nagasaki

856-8562

Ohmura

634-8522

Kashihara

949-3193

Jyo-etsu

874-0011

Beppu

570-8506

Moriguchi

530-0012

Osaka

545-8586

Osaka

589-0011

Sayama

589-8511

Sayama

330-0074

Saitama

431-3192

Hamamatsu

120-0033

Adachi-ku

113-0021

Bunkyo-ku

113-8603

Bunkyo-ku

101-8643

Chiyoda-ku

102-8161

Chiyoda-ku

173-0015

Itabashi-ku

187-8551

Kodaira

152-0012

Meguro-ku

152-8902

Meguro-ku

153-8515

Meguro-ku

107-0052

Minato-ku

107-0062

Minato-ku

164-0003

Nakano-ku

143-8541

Ohta-ku

154-0004

Setagaya-ku

160-0023

Shinjuku

190-0012

Tachikawa

170-0002

Toshima-ku

170-0005

Toshima-ku

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00225524 - Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression. | Biotech Hunter | Biotech Hunter